Company profile CRVS
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. Corvus Pharmaceuticals expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 46 | 91 97.8% QoQ | 161 76.9% QoQ | 80 -50.3% QoQ |
| 2020 | 71 54.3% YoY -11.2% QoQ | 78 -14.3% YoY 9.9% QoQ | 140 -13.0% YoY 79.5% QoQ | 49 -38.8% YoY -65.0% QoQ |
| 2021 | 106 49.3% YoY 116.3% QoQ | 107 37.2% YoY 0.9% QoQ | 171 22.1% YoY 59.8% QoQ | 33 -32.7% YoY -80.7% QoQ |
| 2022 | 54 -49.1% YoY 63.6% QoQ | 77 -28.0% YoY 42.6% QoQ | 128 -25.1% YoY 66.2% QoQ | 61 84.8% YoY -52.3% QoQ |
| 2023 | 31 -42.6% YoY -49.2% QoQ | 67 -13.0% YoY 116.1% QoQ | 93 -27.3% YoY 38.8% QoQ | 71 16.4% YoY -23.7% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of Corvus Pharmaceuticals was 6.57 per week. The last year interest of Corvus Pharmaceuticals compared to the last 5 years has changed by -29.22%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -40.15%.
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. Corvus Pharmaceuticals stock expected interest is significantly lower compared to previous quarter (-100.0%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 113 | 111 -1.8% QoQ | 52 -53.2% QoQ | 59 13.5% QoQ |
| 2020 | 89 -21.2% YoY 50.8% QoQ | 118 6.3% YoY 32.6% QoQ | 201 286.5% YoY 70.3% QoQ | 84 42.4% YoY -58.2% QoQ |
| 2021 | 97 9.0% YoY 15.5% QoQ | 103 -12.7% YoY 6.2% QoQ | 217 8.0% YoY 110.7% QoQ | 129 53.6% YoY -40.6% QoQ |
| 2022 | 122 25.8% YoY -5.4% QoQ | 0 -100.0% YoY -100.0% QoQ | 92 -57.6% YoY inf% QoQ | 133 3.1% YoY 44.6% QoQ |
| 2023 | 0 -100.0% YoY -100.0% QoQ | 97 inf% YoY inf% QoQ | 101 9.8% YoY 4.1% QoQ | 46 -65.4% YoY -54.5% QoQ |
| 2024 | 0 -65.4% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of Corvus Pharmaceuticals stock was 7.52 per week. The last year interest of Corvus Pharmaceuticals stock compared to the last 5 years has changed by -37.63%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -31.13%.
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. Corvus Pharmaceuticals news expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 89 | 145 62.9% QoQ | 188 29.7% QoQ | 0 -100.0% QoQ |
| 2020 | 0 -100.0% YoY -100.0% QoQ | 57 -60.7% YoY inf% QoQ | 113 -39.9% YoY 98.2% QoQ | 96 inf% YoY -15.0% QoQ |
| 2021 | 139 inf% YoY 44.8% QoQ | 68 19.3% YoY -51.1% QoQ | 136 20.4% YoY 100.0% QoQ | 259 169.8% YoY 90.4% QoQ |
| 2022 | 96 -30.9% YoY -62.9% QoQ | 162 138.2% YoY 68.8% QoQ | 26 -80.9% YoY -84.0% QoQ | 45 -82.6% YoY 73.1% QoQ |
| 2023 | 197 105.2% YoY 337.8% QoQ | 0 -100.0% YoY -100.0% QoQ | 81 211.5% YoY inf% QoQ | 205 355.6% YoY 153.1% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of Corvus Pharmaceuticals news was 8.05 per week. The last year interest of Corvus Pharmaceuticals news compared to the last 5 years has changed by -2.11%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by -2.96%.
There is not enough data for CPI-006 immuno-oncology therapy to provide analysis
There is not enough data for CPI-006 immuno-oncology therapy to provide correlation calculation
There is not enough data for CPI-006 immuno-oncology therapy to provide analysis
There is not enough data for CPI-006 clinical trial to provide analysis
There is not enough data for CPI-006 clinical trial to provide correlation calculation
There is not enough data for CPI-006 clinical trial to provide analysis
There is not enough data for CPI-818 ITK inhibitor to provide analysis
There is not enough data for CPI-818 ITK inhibitor to provide correlation calculation
There is not enough data for CPI-818 ITK inhibitor to provide analysis
There is not enough data for CPI-818 clinical trial to provide analysis
There is not enough data for CPI-818 clinical trial to provide correlation calculation
There is not enough data for CPI-818 clinical trial to provide analysis
There is not enough data for CPI-444 A2A receptor antagonist to provide analysis
There is not enough data for CPI-444 A2A receptor antagonist to provide correlation calculation
There is not enough data for CPI-444 A2A receptor antagonist to provide analysis
There is not enough data for CPI-444 clinical trial to provide analysis
There is not enough data for CPI-444 clinical trial to provide correlation calculation
There is not enough data for CPI-444 clinical trial to provide analysis
There is not enough data for Corvus Pharmaceuticals headquarters to provide analysis
There is not enough data for Corvus Pharmaceuticals headquarters to provide correlation calculation
There is not enough data for Corvus Pharmaceuticals headquarters to provide analysis